Back to Search
Start Over
The antioxidant drink 'effective microorganism-X (EM-X)' pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson’s disease
- Source :
- Journal of Pharmacy and Pharmacology. 56:649-654
- Publication Year :
- 2004
- Publisher :
- Oxford University Press (OUP), 2004.
-
Abstract
- There is continued interest in the assessment and potential use of antioxidants as neuroprotective agents in diseases associated with increased oxidative stress, such as Parkinson's disease. The neuroprotective effect of a natural antioxidant drink, EM-X (a ferment derivative of unpolished rice, papaya and seaweeds with effective microorganisms), was investigated using the 6-hydroxydopamine (6-OHDA)-lesion rat model of Parkinson's disease. The nigrostriatal dopaminergic neurons were unilaterally lesioned with 6-OHDA (8 μg) in rats that were treated with a 10-times diluted EM-X drink (dilEM-X), standard EM-X drink (stdEM-X) or tap water for 4 days. Seven days post lesion, the integrity (no. of tyrosine hydroxylase positive cells (TH+ cells) in the substantia nigra pars compacta (SNpc)) and functionality (dopamine and its metabolites DOPAC and HVA content in the striata) of nigrostriatal dopaminergic neurons were assessed. In the vehicle-treated rats, infusion of 8 μg of 6-OHDA significantly reduced the number of TH+ cells in the SNpc as well as the levels of dopamine, DOPAC and HVA in the striata on the lesion side. The loss of TH+ cells, dopamine and HVA, but not the DOPAC levels, was significantly attenuated by stdEM-X pretreatment, but not by the dilEM-X pretreatment. There were no significant changes in the TH+ cells, or in the monoamine levels with the EM-X pretreatment per se, except for a small but significant fall in the levels of dopamine with the stdEM-X. The evidence presented supports the potential neuroprotective effects of stdEM-X drink, although its effect on dopamine levels needs further investigation.
- Subjects :
- Male
medicine.medical_specialty
Time Factors
Parkinson's disease
Tyrosine 3-Monooxygenase
Dopamine
Pharmaceutical Science
Substantia nigra
Neuroprotection
Antioxidants
Beverages
Rats, Sprague-Dawley
Internal medicine
medicine
Animals
Glycosides
Kaempferols
Oxidopamine
Neurons
Pharmacology
Dose-Response Relationship, Drug
Tyrosine hydroxylase
Pars compacta
Chemistry
Dopaminergic
Parkinson Disease
medicine.disease
Corpus Striatum
Rats
Substantia Nigra
Neuroprotective Agents
Endocrinology
Monoamine neurotransmitter
nervous system
Biochemistry
3,4-Dihydroxyphenylacetic Acid
medicine.drug
Subjects
Details
- ISSN :
- 20427158 and 00223573
- Volume :
- 56
- Database :
- OpenAIRE
- Journal :
- Journal of Pharmacy and Pharmacology
- Accession number :
- edsair.doi.dedup.....8b28d9ce2ad5052b1c4fda5ac89f5a54
- Full Text :
- https://doi.org/10.1211/0022357023222